Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): A clinicopathologic study of 24 Japanese cases

International Journal of Surgical Pathology

Volumn 14, Issue 1, 2006, Pages 43-48

  Kojima, Masaru ^a,b   Itoh, Hideaki ^c   Shimizu, Kazuhiko ^d   Saruki, Nobuhiro ^a   Murayama, Kayoko ^a   Higuchi, Keiko ^a   Tamaki, Yoshio ^a   Matsumoto, Morio ^e   Hirabayashi, Kaoru ^f   Igarishi, Seiji ^f   Masawa, Nobuhide ^b   Nakamura, Shigeo ^g  

^a GUNMA CANCER CENTER HOSPITAL   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c MAEBASHI RED CROSS HOSPITAL   (Japan)

^d ASHIKAGA RED CROSS HOSPITAL   (Japan)

^e National Nishigunma Hospital   (Japan)

^f TOCHIGI CANCER CENTER   (Japan)

^g NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Epstein Barr virus; Histopathology; Immunohistochemistry; Malignant lymphoma; Systemic rheumatic disease

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; DERMATOMYOSITIS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; LYMPHOMA; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T CELL LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; ARTHRITIS, RHEUMATOID; DERMATOMYOSITIS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RHEUMATIC DISEASES; RNA, VIRAL; SCLERODERMA, SYSTEMIC;

EID: 32344451274     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-3131.2006.00004.x     Document Type: Article

References (28)

1. Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma and myeloma in patients with rheumatoid arthritis. J Chron Dis 31:691-696, 1978
2. Leandro MJ, Isenberg DA. Rheumatic disease and malignancy-is there an association? Scand J Rheumatol 30:185-188, 2001
3. Thomas E, Brewster DH, Black RJ, MacFarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88:497-502, 2000
4. Frizzera G. Immunosuppression, autoimmunity, and lymphoproliferative disorders. Hum Pathol 25:627-629, 1994
5. Kamel OW, van de Rijn M, Lebrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25:638-643, 1994
6. Kamel OW. Iatrogenic lymphoproliferative disorders in nontransplantation settings. Semin Diag Pathol 14:27-34, 1997
7. Kamel OW, Weiss LM, van de Rijin M, Colvy TV, Kingma DW, Jaffe ES. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol 20:1279-1287, 1996
8. Ioachim HL. Lymph node pathology, 3rd ed. JB Lippincott, Philadelphia, pp. 261-263, 2003
9. Banks PM, Witrak GA, Conn DL. Lymphoid neoplasia following connective tissue disease. Mayo Clin Proc 54:104-108, 1979
10. Symmons DPM, Ahern M, Bacon PA, Hawkins CF, Amlot PL, Jones EL, Prior P Scott DL. Lymphoproliferative malignancy in rheumatoid arthritis: A study of 20 cases. Ann Rheum Dis 43:132-135, 1984
11. Kojima M, Nakamura S, Futamura N, Kurabayashi Y, Ban S, Itoh H, Yoshida K, Joshita T, Suchi T. Malignant lymphoma in patients with rheumatic disease other than Sjögren's syndrome: A clinicopathologic study of five cases and a review of the Japanese literature. Jpn J Clin Oncol 27:84-90, 1997
12. Hoshida Y, Tomita Y, Zhiming D, Yamauchi A, Nakatsuka S-I, Kurasono Y, Arima Y, Tsudo M, Shintaku M, Aozasa K. Lymphoproliferative disorders in autoimmune disease in Japan: Analysis of clinicopathologic features and Epstein-Barr virus infection. Int J Cancer 108:443-449, 2004
13. Green JA, Dawson AA, Walker W. Systemic lupus erythematos us and lymphoma. Lancet ii:753-756, 1978
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Am J Stat Assoc 53:457-481, 1958
15. Peto PE, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantle N, McPherson K, Peto J, Smith G. Design and analysis of randomized clinical trails requiring prolonged observation of each patient. Br J Cancer 35:1-39, 1977
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
17. Kumar V, Cotran RS, Robbins SL. Basic pathology, 7th ed, W.B. Saunders, Philadelphia, pp. 103-164, 2003
18. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
19. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-347, 1975
20. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). IARC Press, Lyon, 2001
21. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphoma in Japan: Incidence of recently recognized entities. Pathol Int 50:696-702, 2000
22. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rossenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-282, 2004
23. Kojima M, Motoori T, Itoh H, Shimizu K, Iijima M, Tamaki Y, Murayama K, Ohno Y, Yoshida K, Masawa N, Nakamura S. Distribution of Epstein-Barr virus in systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, and dermatomyositis) associated lymphadenopathy. A study of 49 cases. Int J Surg Pathol 13:2005 (in press)
24. Beacklund E, Sundström C, Ekbon A, Catrina AI, Biberfeld P, Peltelius N, Klareskog L. Lymphoma subtypes in patients with rheumatoid arthritis. Increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48:1543-1550, 2003
25. Allzadeh AA, Elsen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tlbshfrani R, Sherlock G, Chan WC, Grelner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown P, Staudt LM. Distinct type of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 40:3503-3511, 2000
26. Plater-Zyberk C, Maini RN, Lam K, Kennedy TD, Janossy G. A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytoc leukemia. Arthrits Rheum 28:971-976, 1985
27. Dauphinée, Tovar Z, Talal N. B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum 31:642-647, 1988
28. Kamel OW, Holly EA, van de Rijin M, Lele C, Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol 29:1676-1680, 1999